Published in Platelets on January 01, 1998
Beta3 integrin haplotype influences gene regulation and plasma von Willebrand factor activity. Atherosclerosis (2007) 0.79
Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr (1992) 1.67
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
[Update on the epidemiology of malaria in French Guiana]. Med Trop (Mars) (2009) 1.50
Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest (1982) 1.50
Systemic but not renal production of prostacyclin is highly reduced in cyclosporin-treated heart transplant recipients. Am J Cardiol (1993) 1.39
A simple and efficient method for platelet isolation from their plasma. Thromb Res (1980) 1.26
Pseudomembranous colitis probably due to rifampicin. Lancet (1980) 1.22
Rapid purification and partial characterization of human platelet glycoprotein IIIb. Interaction with thrombospondin and its role in platelet aggregation. J Biol Chem (1989) 1.18
Glycoproteins of platelet membranes from Glanzmann's thrombasthenia. A comparison with normal using carbohydrate-specific or protein-specific labelling techniques and high-resolution two-dimensional gel electrophoresis. Eur J Biochem (1981) 1.13
Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke (1998) 1.08
Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients. Haemostasis (1975) 1.06
One-step procedure for the rapid isolation of mouse monoclonal antibodies and their antigen binding fragments by fast protein liquid chromatography on a mono Q anion-exchange column. J Chromatogr (1985) 1.03
Survival of avian influenza and Newcastle disease viruses in compost and at ambient temperatures based on virus isolation and real-time reverse transcriptase PCR. Avian Dis (2009) 1.02
Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. Thromb Res (1980) 0.99
Monoclonal antibodies against platelet membrane glycoproteins. Characterization and effect on platelet function. Eur J Biochem (1983) 0.99
[Letter: Cholostatic jaundice caused by carbimazole]. Nouv Presse Med (1973) 0.97
The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0. Blood Coagul Fibrinolysis (1998) 0.97
Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Arthritis Rheum (1998) 0.96
Complex formation of human thrombospondin with osteonectin. Eur J Biochem (1988) 0.96
Thrombocytopenia, macrothrombocytopathia, nephritis and deafness. Am J Med (1976) 0.95
ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families. Blood (1999) 0.93
Synthesis of GPIb beta with novel transmembrane and cytoplasmic sequences in a Bernard-Soulier patient resulting in GPIb-defective signaling in CHO cells. J Thromb Haemost (2006) 0.92
Identification of human platelet glycoproteins in SDS-polyacrylamide gels using 125I labelled lectins. Thromb Res (1979) 0.90
Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. Thromb Res (1984) 0.89
Isolation of thrombospondin released from thrombin-stimulated human platelets by fast protein liquid chromatography on an anion-exchange Mono-Q column. J Chromatogr (1984) 0.89
Role of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids. Adv Exp Med Biol (1985) 0.88
Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors. J Thorac Cardiovasc Surg (1993) 0.87
Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. Thromb Res (1988) 0.86
Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. Endocrinology (1992) 0.86
A comparison of the major platelet membrane glycoproteins from Bernard-Soulier syndrome with normals after radiolabelling of sialic acid or terminal galactose/N-acetylgalactosamine residues. Thromb Res (1980) 0.86
Population pharmacokinetics of recombinant factor VIIa in volunteers anticoagulated with acenocoumarol. Thromb Haemost (1998) 0.86
Antiprothrombinase and factor II deficiency in a non SLE patient. Thromb Haemost (1981) 0.86
Studies on platelet glycoproteins in Glanzmann's thrombasthenia using 125I-labelled lectins. Br J Haematol (1980) 0.86
Description of 10 new mutations in platelet glycoprotein IIb (alphaIIb) and glycoprotein IIIa (beta3) genes. Platelets (2001) 0.84
Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Correlations of outcome with clinical and radiological data. Stroke (1996) 0.84
Lipoxygenase activity of intact human platelets. Prostaglandins Leukot Med (1984) 0.83
Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosis. Br J Haematol (1985) 0.83
Identification of two distinct regions within the binding sites for fibrinogen and fibronectin on the IIb-IIIa human platelet membrane glycoprotein complex by monoclonal antibodies P2 and P4. Eur J Biochem (1986) 0.82
Inhibition of thrombin-induced platelet arachidonic acid release by 15-hydroperoxy-arachidonic acid. Biochem Biophys Res Commun (1981) 0.81
[The COMPAQH project: researches on quality indicators in hospitals]. Rev Epidemiol Sante Publique (2008) 0.81
Two novel mutations in EGF-like domains of human factor IX dramatically impair intracellular processing and secretion. J Thromb Haemost (2004) 0.81
Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: a study in healthy male subjects. Can J Physiol Pharmacol (1996) 0.81
Two novel fibrinogen variants found in patients with pulmonary embolism and their families. J Thromb Haemost (2003) 0.81
Treatment effectiveness in an adolescent chemical dependency treatment program: a quasi-experimental design. Int J Addict (1985) 0.81
Prostaglandin E2-like activity of 20:3n-9 platelet lipoxygenase end-product. FEBS Lett (1985) 0.81
Polyunsaturated fatty acids: drug or food? World Rev Nutr Diet (1984) 0.81
Comparative evaluation of plasma thrombospondin beta-thromboglobulin and platelet factor 4 in acute myocardial infarction. Thromb Res (1985) 0.81
Constitutional thrombocytopathy with subnormal response to thromboxane A2. Br J Haematol (1981) 0.81
Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase. Br J Haematol (1978) 0.80
A factor VIII minigene comprising the truncated intron I of factor IX highly improves the in vitro production of factor VIII. Thromb Haemost (2001) 0.80
Development of methods for detection and quantification of avian influenza and Newcastle disease viruses in compost by real-time reverse transcription polymerase chain reaction and virus isolation. Poult Sci (2008) 0.80
Influence of temperature on survival and conjugative transfer of multiple antibiotic-resistant plasmids in chicken manure and compost microcosms. Poult Sci (2007) 0.80
Antithrombin III deficiency during continuous venovenous hemodialysis. Contrib Nephrol (1995) 0.80
Platelet phospholipid in stroke. Clin Chim Acta (1978) 0.79
Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospholipids. Prostaglandins (1980) 0.79
Tryptic peptide map analysis of the major human blood platelet membrane glycoproteins separated by two-dimensional polyacrylamide gel electrophoresis. Biochim Biophys Acta (1982) 0.79
Osteonectin is an alpha-granule component involved with thrombospondin in platelet aggregation. J Bone Miner Res (1991) 0.79
In vitro incorporation and metabolism of some icosaenoic acids in platelets. Effect on arachidonic acid oxygenation. Biochim Biophys Acta (1985) 0.79
A comparison of techniques used to study externally oriented proteins and glycoproteins of human blood platelets. Thromb Res (1979) 0.79
Thalamic stroke and congenital factor V deficiency. Stroke (1991) 0.79
Ectopic pregnancy and occupational exposure of hospital personnel. Scand J Work Environ Health (1998) 0.79
Expression of adhesion molecules in endothelial cells during allogeneic bone marrow transplantation. Eur J Haematol (1994) 0.79
Increase of platelet prostaglandin cyclic endoperoxides in thrombosis. Lancet (1977) 0.78
[Fibrinolytic activity of platelets]. Nouv Presse Med (1973) 0.78
Detection of inhaled pentamidine in health care workers. N Engl J Med (1991) 0.78
Effects of ticlopidine on platelet prostaglandin metabolism. Possible consequences for prostacyclin production. Prostaglandins Med (1979) 0.78
Increased thrombosis incidence in a family with an inherited protein S deficiency and a high oxygen affinity hemoglobin variant. Am J Hematol (1994) 0.78
[Severe viral hepatitis. Intravascular coagulation and fibrinolysis. Radioisotopic study of the life of platelets and fibrinogens]. Presse Med (1971) 0.78
Human plasma fibrinogen measurement derived from activated partial thromboplastin time clot formation. Blood Coagul Fibrinolysis (2002) 0.78
Urine pentamidine as an indicator of lung pentamidine in patients receiving aerosol therapy. Chest (1991) 0.78
Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations. Thromb Haemost (1999) 0.78
Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIa. Thromb Haemost (1989) 0.78
Decrease of platelet activity after intake of small amounts of eicosapentaenoic acid in diabetics. Thromb Haemost (1982) 0.78
Total plasma antioxidant capacity in cystic fibrosis. Pediatr Pulmonol (2000) 0.78
Identification and characterization of fragments of major glycoproteins from platelet membrane after chymotrypsin treatment. Eur J Biochem (1985) 0.78
Illegitimate transcription: its use for studying genetic abnormalities in lymphoblastoid cells from patients with Glanzmann thrombasthenia. Br J Haematol (1998) 0.78
Electron quantum optics: partitioning electrons one by one. Phys Rev Lett (2012) 0.78
Immunofluorescence study of mucosal B lymphocytes in bile reflux gastritis. Digestion (1979) 0.78
Tandem separation of labelled human blood platelet membrane glycoproteins by anion-exchange and gel fast protein liquid chromatography. J Chromatogr (1985) 0.78
Evaluation of coagulation equilibrium at baseline and during factor VIII and factor IX replacement in haemophiliacs. Blood Coagul Fibrinolysis (1998) 0.77
Degradation of foot-and-mouth disease virus during composting of infected pig carcasses. Can J Vet Res (2010) 0.77
Human platelet PGE1 and dihomogammalinolenic acid. Comparison to PGE2 and arachidonic acid. Prog Lipid Res (1981) 0.77
Thrombin decreases platelet cyclic AMP in the absence of prostaglandin synthesis. Biomedicine (1977) 0.77
Significant reduction in the binding of a monoclonal antibody (LYP 18) directed against the IIb/IIIa glycoprotein complex to platelets of patients having undergone extracorporeal circulation. Thromb Haemost (1987) 0.77
Simultaneous enzymo-immunologic assays of platelet associated IgG, IgM and C3. A useful tool in assessment of immune thrombocytopenias. Thromb Res (1982) 0.77
Uptake and effect on arachidonic acid oxygenation of some icosaenoic acids in human platelets. Biomed Biochim Acta (1984) 0.77
[Alterations in hemostasis during treatment with sodium dipropylacetate (Depakine) (R)]. Pediatrie (1979) 0.77
Thromboangiitis obliterans with inaugural rheumatic manifestations. A report of three cases. Rev Rhum Engl Ed (1997) 0.77
Refractoriness of diabetic platelets to inhibitory prostaglandins. Prostaglandins Med (1981) 0.77
Fatty acid composition in native and cultured human endothelial cells. In Vitro (1984) 0.76
Thrombomodulin is synthesized by osteoblasts, stimulated by 1,25-(OH)2D3 and activates protein C at their cell membrane. Endocrinology (1993) 0.76
Efficacy and safety of continuous infusion of Mononine during five surgical procedures in three hemophilic patients. Am J Hematol (1998) 0.76
Molecular study of Glanzmann thrombasthenia in 3 patients issued from 2 different families. Thromb Haemost (1995) 0.76